Timothy P. Coughlin
Chairman
aTYR PHARMA INC (ATYR)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Timothy P. Coughlin
Timothy P. Coughlin is recorded as Chairman at aTYR PHARMA INC (ATYR). aTYR PHARMA INC reported in an 8-K filed May 19, 2023 that Timothy P. Coughlin was appointed Class II director, effective May 17, 2023.
“The election of two Class II directors, as nominated by the Board, to hold office until the 2026 annual meeting of stockholders or until their successors are duly elected and qualified”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Start not stated–present
-
Start not stated–2023-03-29
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at aTYR PHARMA INC
Other people whose current roles at this company are on record from its filings.
- Sanjay Shukla CEO, Board Member
- Jill Broadfoot CFO
- Nancy E. Denyes General Counsel
- Eric Benevich Board Member
- Jane A. Gross Board Member
- Jane A. Gross, Ph.D. Board Member
- Paul Schimmel Board Member
- Paul Schimmel, Ph.D. Board Member
- Sanjay S. Shukla, M.D., M.S. Board Member
- Sara L. Zaknoen Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.